Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9392 |
High Similarity |
NPD1512 |
Approved |
0.9257 |
High Similarity |
NPD1511 |
Approved |
0.9026 |
High Similarity |
NPD1934 |
Approved |
0.8974 |
High Similarity |
NPD3882 |
Suspended |
0.8968 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8968 |
High Similarity |
NPD2801 |
Approved |
0.891 |
High Similarity |
NPD3817 |
Phase 2 |
0.882 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.882 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.882 |
High Similarity |
NPD6166 |
Phase 2 |
0.878 |
High Similarity |
NPD6797 |
Phase 2 |
0.8727 |
High Similarity |
NPD7251 |
Discontinued |
0.8693 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8675 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8563 |
High Similarity |
NPD7808 |
Phase 3 |
0.8545 |
High Similarity |
NPD7054 |
Approved |
0.8494 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8485 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8477 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8477 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8467 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8438 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8421 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8418 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8387 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8385 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8383 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8344 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8333 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8312 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8301 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8261 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8224 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.8214 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8199 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8187 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.817 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8133 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8121 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8118 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8079 |
Intermediate Similarity |
NPD943 |
Approved |
0.8079 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8047 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7987 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7974 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7964 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7952 |
Intermediate Similarity |
NPD919 |
Approved |
0.7917 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7843 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7843 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7821 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7815 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7765 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7765 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7764 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7764 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7748 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7719 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7597 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7576 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7569 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7544 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7484 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7459 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD920 |
Approved |
0.7453 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7439 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7432 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7427 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7416 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7389 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD1203 |
Approved |
0.738 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7353 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7351 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7349 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7312 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD1653 |
Approved |
0.729 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7278 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7278 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7261 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7237 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7237 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD37 |
Approved |
0.7233 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7232 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7229 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7216 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7209 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7207 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7204 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7204 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.72 |
Intermediate Similarity |
NPD5710 |
Approved |
0.72 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7196 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7196 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7196 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7196 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7196 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7196 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7196 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7191 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7173 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7169 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7167 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7161 |
Intermediate Similarity |
NPD1470 |
Approved |
0.716 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7158 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7125 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7119 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7115 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7108 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7102 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7099 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7081 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7078 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7078 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7055 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7055 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7055 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7055 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7051 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7044 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7035 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.6995 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6995 |
Remote Similarity |
NPD7698 |
Approved |
0.6995 |
Remote Similarity |
NPD7697 |
Approved |
0.6994 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.699 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6984 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6984 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6979 |
Remote Similarity |
NPD2494 |
Approved |
0.6979 |
Remote Similarity |
NPD3452 |
Approved |
0.6979 |
Remote Similarity |
NPD2493 |
Approved |
0.6979 |
Remote Similarity |
NPD3450 |
Approved |
0.6966 |
Remote Similarity |
NPD5242 |
Approved |
0.6962 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD7874 |
Approved |
0.6954 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD2354 |
Approved |
0.6943 |
Remote Similarity |
NPD3267 |
Approved |
0.6943 |
Remote Similarity |
NPD3266 |
Approved |
0.6939 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6937 |
Remote Similarity |
NPD411 |
Approved |
0.6931 |
Remote Similarity |
NPD6535 |
Approved |
0.6931
|
Remote Similarity |
NPD6534 |
Approved |